retatrutide effects clinical trial retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity Extreme Side Effects Followed Overdose

Theres a possible increase in the risk of gallbladder disease in people taking semaglutide for more than six months

49,66 Metabolic benefits of GLP-1RA in the management of weight-related MASLD MASLD is highly correlated with other metabolic disorders and may even be a mutual cause, compounded by a wide range of disease development stages, making its management highly complex

Nicotine A trial of 84 smokers with prediabetes and overweight found that exenatide was superior to placebo in terms of nicotine abstinence rates at 6 weeks 118

Patients interested in access should speak to their GP about legitimate research pathways via the NIHR Be Part of Research portal

Lower cost and injection burden while still capturing most of the synergy benefit around glucose metabolism